David V. Smith
2018
Compensation breakdown
| Option Awards | $1,474,432 |
|---|---|
| Salary | $44,103 |
| Stock Awards | $498,800 |
| Other | $1,075 |
| Total | $2,018,409 |
Smith received $1.5M in option awards, accounting for 73% of the total pay in 2018.
Smith also received $44.1K in salary, $498.8K in stock awards and $1.1K in other compensation.
Rankings
In 2018, David V. Smith's compensation ranked 5,707th out of 14,244 executives tracked by ExecPay. In other words, Smith earned more than 59.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,707 out of 14,244 | 60th |
Division Manufacturing | 2,157 out of 5,759 | 63rd |
Major group Chemicals And Allied Products | 798 out of 2,122 | 62nd |
Industry group Drugs | 666 out of 1,811 | 63rd |
Industry Pharmaceutical Preparations | 515 out of 1,385 | 63rd |
Pay ratio
| David V. Smith's Pay | $2,018,409 |
|---|---|
| Median Employee's Pay | $201,670 |
| Pay Ratio | 10to 1 |
In 2018, the annual total compensation of David V. Smith was $2,018,409.
The annual total compensation of the median employee at Five Prime Therapeutics was $201,670.
The ratio of David V. Smith's pay to the pay of median employee was therefore 10 to one.
Smith's colleagues
We found six more compensation records of executives who worked with David V. Smith at Five Prime Therapeutics in 2018.
2018
Aron Knickerbocker
Five Prime Therapeutics
Chief Executive Officer
2018
Bryan Irving
Five Prime Therapeutics
Chief Scientific Officer
2018
Helen Collins
Five Prime Therapeutics
Chief Medical Officer
2018
Francis Sarena
Five Prime Therapeutics
Secretary
2018
Linda Rubinstein
Five Prime Therapeutics
Chief Financial Officer
2018
Marc Belsky
Five Prime Therapeutics